Ernexa Therapeutics (ERNA) Receivables - Other (2018 - 2026)
Ernexa Therapeutics' Receivables - Other came in at $83,000 for Q2 2026, down 46.1% from $154,000 a year earlier and down 12.6% from the prior quarter.
Powered by 
Analysis
Ernexa Therapeutics (ERNA) Receivables - Other (2018 - 2026) Analysis & Trends
At the end of FY2025, Ernexa Therapeutics' Receivables - Other was $95,000, down 78.3% from FY2024.
- Receivables - Other carries a five-year compound annual growth rate of -3.2% (FY2020 to FY2025).
- Going back by year, Receivables - Other was $437,000 in FY2024 (+2.8%), $425,000 in FY2023 (-55.3%), $951,000 in FY2022 (+39.0%) and $684,000 in FY2021 (+510.7%).
- The Q2 2026 figure represents the lowest quarterly Receivables - Other in data going back to Q4 2018.
- Year-over-year, Receivables - Other has declined for six consecutive quarters, with an average decline of 44.5% over the last eight quarters.
- The fastest year-over-year change in Receivables - Other over five years came in Q4 2021 (growth of 510.7%), and the weakest in Q3 2024 (a decline of 89.5%).
- Business Quant data shows ERNA's Receivables - Other at $95,000 (Q1 2026), $95,000 (Q4 2025) and $153,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Ernexa Therapeutics | 3.31 Mn | -18.41 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 58,000.00 |
| Jun 30, 2026 | 83,000.00 |
| Mar 31, 2026 | 95,000.00 |
| Dec 31, 2025 | 95,000.00 |
| Sep 30, 2025 | 153,000.00 |
| Jun 30, 2025 | 154,000.00 |
| Mar 31, 2025 | 156,000.00 |
| Dec 31, 2024 | 437,000.00 |
| Sep 30, 2024 | 187,000.00 |
| Jun 30, 2024 | 228,000.00 |
| Mar 31, 2024 | 351,000.00 |
| Dec 31, 2023 | 425,000.00 |
| Sep 30, 2023 | 1.78 Mn |
| Jun 30, 2023 | 984,000.00 |
| Mar 31, 2023 | 647,000.00 |
| Dec 31, 2022 | 951,000.00 |
| Sep 30, 2022 | 926,000.00 |
| Jun 30, 2022 | 694,000.00 |
| Mar 31, 2022 | 835,000.00 |
| Dec 31, 2021 | 684,000.00 |
API Access
Ernexa Therapeutics Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=ERNA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "ERNA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=ERNA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();